Goldman Sachs
MJN

Goldman Sachs’s Mead Johnson Nutrition Company MJN Stock Holding History

Goldman Sachs’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3,696,172
Closed -$329M – 7144
2017
Q1 		$329M Buy
3,696,172
+2,434,090
+193% +$200M 0.09% 204
2016
Q4 		$89.3M Sell
1,262,082
-148,790
-11% -$11.1M 0.03% 845
2016
Q3 		$111M Sell
1,410,872
-1,021,103
-42% -$87.1M 0.03% 655
2016
Q2 		$221M Buy
2,431,975
+815,671
+50% +$69.1M 0.07% 308
2016
Q1 		$137M Sell
1,616,304
-5,102,954
-76% -$380M 0.05% 505
2015
Q4 		$530M Buy
6,719,258
+4,652,692
+225% +$367M 0.17% 98
2015
Q3 		$145M Buy
2,066,566
+171,556
+9% +$14.1M 0.05% 437
2015
Q2 		$171M Buy
1,895,010
+1,159,105
+158% +$112M 0.05% 402
2015
Q1 		$74M Sell
735,905
-271,057
-27% -$27.3M 0.02% 814
2014
Q4 		$101M Sell
1,006,962
-150,620
-13% -$15M 0.03% 676
2014
Q3 		$111M Buy
1,157,582
+551,252
+91% +$52.2M 0.04% 587
2014
Q2 		$56.5M Buy
606,330
+80,466
+15% +$7.04M 0.02% 1003
2014
Q1 		$43.7M Sell
525,864
-270,498
-34% -$21.9M 0.01% 1153
2013
Q4 		$66.7M Sell
796,362
-21,759
-3% -$1.77M 0.02% 863
2013
Q3 		$60.8M Sell
818,121
-281,640
-26% -$21.1M 0.02% 848
2013
Q2 		$87.1M Buy
+1,099,761
New +$88.2M 0.03% 605

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.55B AUM 27.24% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.54B AUM 37.12% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Goldman Sachs's MJN Position: Q2 2017 in Review

Goldman Sachs sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 3,696,172 shares — an estimated $329M sold.

Goldman Sachs first reported a position in MJN in Q2 2013 and held it in 16 quarters. The position peaked at $530M in Q4 2015. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Goldman Sachs reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Goldman Sachs sold 3,696,172 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $329M.
  • Goldman Sachs first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 16 quarters.
  • Goldman Sachs's Mead Johnson Nutrition Company position peaked at $530M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Goldman Sachs's 13F filing for Q2 2017, filed 14 Aug 2017.